AbbVie Unit Offers $500 for Natrelle Implant Testimonials

AbbVie Unit Offers $500 Incentive in New Natrelle Campaign

On February 3, 2026, Allergan Aesthetics, a division of pharmaceutical giant AbbVie (NYSE: ABBV), initiated the "Faces of Natrelle®" testimonial program. This nationwide marketing campaign invites women who have received Natrelle® breast implants for either augmentation or reconstruction to share their personal experiences. To incentivize participation, the company is offering $500 in Allē gift cards to selected augmentation patients whose testimonials are approved for use in the brand's marketing channels.

Strategy Aims to Solidify Market-Leading Position

The campaign is a strategic move to address what the company calls "outdated perceptions and a lingering culture of silence" surrounding breast procedures. By crowdsourcing patient stories, Allergan aims to build a library of authentic content to support prospective patients and increase transparency. Natrelle® is already the #1 breast implant brand selected by plastic surgeons, according to a September 2025 survey, and this initiative appears designed to solidify that market leadership through direct-to-consumer engagement.

Faces of Natrelle® is about honoring the stories, the decisions, and the transformations of women with breast implants.

— Nicole Mowad-Nassar, President, Global Allergan Aesthetics and Senior Vice President, AbbVie.

While the program is a notable marketing effort within the aesthetics division, its financial impact on the parent company is expected to be limited. Analysts do not anticipate a material change in AbbVie's stock performance resulting from this specific product-level campaign, which was announced on a day its stock (ABBV) recorded a 1.18% gain.